Skip to NavigationSkip to content

News

Novo Nordisk has been notoriously shy when it comes to making acquisitions, however, according to reports, Novo Nordisk has approached Global Blood...
Indian pharmaceutical firm Dr Reddy’s has seen its shares drop to their lowest point in almost three years after the FDA issued 13 observations...
The trials of cancer treatments in the EU are already at a low level and Brexit has experts worried that children in the UK may lose out even further...
The University of Sheffield and Parkinson’s UK has created, in a first-of-a-kind, a virtual £1 million biotech company for developing therapies...
A new trial in the US hopes to marry a new pair of drugs as a combination treatment for acute myeloid leukaemia (AML), with research suggesting...
The FDA has given the go-ahead for Amgen’s hyperparathyroidism (HPT) therapy Parsabiv (etelcalcetide), marking the first new treatment for patients...
Research has identified that the function of metabolic enzyme AKR1B1 is key to the progression of aggressive ‘basal-like’ breast cancer, meaning an...
A study conducted by researchers from Northwestern Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has given clues as to how...
BeiGene and Guangzhou GET Technology Development will partner in a development deal to construct a biologics manufacturing site in Guangzhou, China;...
A new variant of a human gene which is known to cause significant drug resistance in patients has been discovered by a team of Chinese researchers...